ELAINE BOYLE: Open Payments
NPI 1669499281 · LAPEER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 33 payments from 12 companies in 2025. Trend: 2023 $393 · 2024 $443 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $150 |
| Alkermes, Inc. | 3 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| Novo Nordisk Inc | 3 | $52 |
| Lundbeck LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Tonix Medicines, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: VRAYLAR, VIVITROL, CAPLYTA, REXULTI, TONMYA, QULIPTA, Rybelsus, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
